0 followers
ProLynx (San Francisco, CA), founded in 2009 by Daniel V. Santi, M.D., Ph.D., and Gary W. Ashley, Ph.D., has developed advanced linker technologies and a facile, transformative platform for controlled release of therapeutics from circulating and fixed macromolecular conjugates.
Orchid
1 follower
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Regeneron
104 followers
Vertex Pharmaceuticals
66 followers
Agilent Technologies
72 followers
Verily Life Sciences
38 followers
bluebird bio
40 followers
Ionis Pharmaceuticals
29 followers
Kura Oncology
20 followers
Explore companies